Guru Ownership Trend
Guru Analysis for Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $57.06 M.
Top institutional holders include Renaissance Technologies (RenTech) and Jefferies Group.
Institutional sentiment is currently Bullish. This is evidenced by a $1.77 M net inflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 88.5%. Conversely, Joel Greenblatt reduced exposure by 37.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Pacira BioSciences, Inc. (PCRX)
Major holders include Renaissance Technologies (RenTech) ($43.99 M), Jefferies Group ($9.39 M), Cliff Asness ($4.02 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.29 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.77 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited PCRX. The total reported sell value was $2.75 M.
Yes, 0 managers opened new positions in PCRX, and 2 increased their existing holdings. The total reported buy value was $4.52 M.